Clinical Trial Update: Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial update examines indacaterol's effect on inspiratory capacity and lung function in patients with chronic obstructive pulmonary disease, comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Formoterol (formoterol)
• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis | Conditions: COPD | Phase 1, Phase 2 | Status: COMPLETED